hg_197610.1

Basic information about the TSS

---

TSS ID: hg_197610.1 Species: human Chr: chrX		Start: 134460220 End: 134460240 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: M31642 Distance: 0 GeneID: 3251 HGNC/MGI_ID: HGNC:5157 UniProt_ID:

Gene_name: hypoxanthine phosphoribosyltransferase 1 Gene_symbol: HPRT1 Gene_synonyms: HGPRT Gene_source: HGNC:5157

TATA-Box annotation

---

Distance to TSS:	65
Nearest PromoterID:	NM_000194
Entrez ID:	3251
Nearest Unigene:	Hs.412707
Nearest Refseq:	NM_000194
Nearest Ensembl:	ENSG00000165704
Gene Name:	hypoxanthine phosphoribosyltransferase 1
Gene Alias:	HGPRT|HPRT
Gene Description:	hypoxanthine phosphoribosyltransferase 1
Gene Type:	protein-coding
CpG%:	0.125
GC%:	0.746269
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HPRT1 p2@HPRT1 p3@HPRT1 p4@HPRT1
Sample		p1@HPRT1	p2@HPRT1	p3@HPRT1	p4@HPRT1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	34.48	80.26	27.86	7.79
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	31.97	82.55	25.09	5.46
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	36.07	85.26	23.92	6.56
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	24.12	74.22	20.79	5.41
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	31.27	82.79	23.40	6.30
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	28.88	84.11	18.22	5.62
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	32.25	118.53	30.07	6.32
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	30.28	106.33	31.00	7.51
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	27.57	86.77	27.36	6.41
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	20.29	80.57	16.23	6.38
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.91	67.51	13.34	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	13.42	76.03	19.92	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	6.77	18.38	18.38	2.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	7.97	17.89	13.08	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	6.37	14.93	15.15	3.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	7.04	17.60	17.60	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	5.90	13.54	17.25	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	5.91	17.72	13.08	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	5.86	16.53	11.73	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.07	15.95	17.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	6.55	15.90	18.58	2.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	7.94	16.23	19.51	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	4.27	14.99	16.93	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	7.04	15.05	15.29	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	6.97	17.03	19.35	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	7.28	14.56	21.52	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	8.24	18.68	17.03	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	4.24	16.74	18.15	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	4.68	18.74	21.48	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	8.14	16.83	16.29	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.65	15.28	16.12	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	6.25	16.02	17.19	3.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	6.75	17.94	17.94	4.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.90	19.63	22.10	3.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.73	16.08	13.28	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	4.41	15.71	16.29	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.54	15.53	16.76	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.65	17.73	14.71	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	7.83	17.83	15.13	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.64	14.16	16.56	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	5.18	13.88	14.59	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.78	18.30	14.93	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	5.69	15.18	14.76	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.44	15.73	16.61	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	5.82	16.86	12.85	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.28	17.45	17.22	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.72	16.31	13.19	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	6.56	18.18	15.50	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	6.46	15.08	15.56	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.67	13.35	12.94	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.76	14.14	13.12	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	7.34	12.68	13.79	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	125.93	27.98	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.39	15.26	16.32	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.29	15.24	13.26	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.01	40.27	25.17	6.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	11.48	16.99	14.24	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	5.19	12.64	10.05	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	7.39	12.85	12.53	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.94	23.26	17.29	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.94	7.05	17.63	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.61	10.65	15.70	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	22.29	25.48	8.76	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.57	12.91	9.17	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.47	10.40	12.67	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.52	11.00	10.29	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	32.33	64.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	47.38	55.28	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	6.83	21.45	21.45	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	13.88	17.36	16.86	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	12.67	15.01	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.26	17.22	15.23	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.52	15.78	16.70	2.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	10.09	12.84	13.76	1.53
Adipocyte - breast, donor1	11376-118A8	8.24	6.49	7.29	1.58
Adipocyte - breast, donor2	11327-117E4	12.35	5.78	4.17	1.28
Adipocyte - omental, donor1	11473-119C6	9.67	5.60	7.51	1.53
Adipocyte - omental, donor2	11474-119C7	5.23	8.22	3.74	1.49
Adipocyte - omental, donor3	11475-119C8	6.36	6.03	3.35	0.33
Adipocyte - perirenal, donor1	11476-119C9	2.55	8.93	6.38	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	3.30	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	6.32	14.45	15.36	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	5.56	8.17	7.65	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	6.85	5.08	5.48	1.76
Adipocyte differentiation, day04, donor2	13022-139D7	7.21	2.57	5.15	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	8.36	3.62	4.74	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	4.70	5.29	7.64	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	8.28	4.50	3.78	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	6.46	4.84	4.52	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	3.73	3.20	2.67	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	4.45	3.90	3.90	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	11.64	1.66	3.74	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	5.78	3.77	4.77	2.01
Adipocyte differentiation, day12, donor3	13027-139E3	3.93	4.58	4.25	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	4.26	0.91	1.83	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	10.39	19.89	18.78	1.77
Alveolar Epithelial Cells, donor2	11590-120G6	1.79	3.94	5.74	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	2.40	5.99	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	5.58	4.68	10.97	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	1.67	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	3.08	1.64	7.60	0.41
Anulus Pulposus Cell, donor1	11248-116E6	12.01	8.35	3.66	3.20
Anulus Pulposus Cell, donor2	11463-119B5	4.90	6.86	3.18	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.68	6.29	3.59	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	10.85	3.91	3.91	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	14.98	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	6.58	6.58	3.89	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	7.59	3.79	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.28	7.92	3.30	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	9.42	5.85	5.52	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.80	9.22	4.85	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.94	8.31	4.75	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	8.29	5.27	1.51	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.81	8.71	5.81	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	10.03	8.78	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.86	5.60	8.24	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	9.55	2.73	2.73	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.69	7.99	5.73	1.66
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.97	5.36	5.89	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.23	6.42	4.91	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.02	5.08	4.81	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	1.95	1.95	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	5.47	5.47	4.64	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	4.80	2.40	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	10.62	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.18	4.80	5.32	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	3.40	4.37	3.88	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.45	5.31	6.07	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	4.85	7.27	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.41	3.42	2.28	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.27	4.92	5.34	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.65	6.71	5.16	1.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.10	5.63	5.63	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.79	3.54	2.89	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	6.42	4.99	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.60	5.26	4.68	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.62	6.32	8.43	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	9.50	5.94	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	9.66	8.14	3.05	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.91	5.60	5.60	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	10.80	4.45	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.93	4.32	4.75	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.35	4.66	4.66	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.09	6.09	5.22	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	10.39	1.89	7.56	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.78	7.80	5.09	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	4.63	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	2.11	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	5.36	6.86	5.57	1.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.22	6.02	4.21	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	5.83	2.19	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.28	5.75	3.68	1.84
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	7.65	7.65	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.59	5.59	8.64	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.12	4.95	4.54	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.26	5.51	6.12	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	7.17	6.21	3.82	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.21	4.43	4.43	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	3.05	10.68	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	5.54	4.98	3.88	2.77
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.83	6.36	4.50	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.09	4.72	5.45	0.73
Astrocyte - cerebellum, donor1	11500-119F6	10.93	16.21	13.02	2.46
Astrocyte - cerebellum, donor2	11580-120F5	5.31	11.98	4.96	1.71
Astrocyte - cerebellum, donor3	11661-122F5	3.15	8.60	7.34	1.47
Astrocyte - cerebral cortex, donor1	11235-116D2	18.48	17.43	15.69	2.79
Astrocyte - cerebral cortex, donor2	11316-117D2	27.99	30.74	17.63	5.82
Astrocyte - cerebral cortex, donor3	11392-118C6	21.93	26.25	16.56	4.77
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	34.06	46.91	41.06	5.85
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	32.45	42.85	35.20	7.77
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	30.95	41.19	35.85	6.94
Basophils, donor1	12241-129G9	9.42	6.02	4.97	1.31
Basophils, donor2	12242-129H1	22.37	10.10	6.13	2.16
Basophils, donor3	12243-129H2	11.47	7.06	5.73	2.65
Bronchial Epithelial Cell, donor1	11511-119G8	6.04	6.25	12.94	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	2.29	5.49	5.94	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	7.17	21.52	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	7.53	8.79	6.90	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	4.78	9.36	7.69	1.87
Bronchial Epithelial Cell, donor6	11461-119B3	5.99	7.14	5.53	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	14.04	9.36	18.89	1.80
Burkitt's lymphoma cell line:DAUDI	10422-106C8	83.47	69.67	23.39	10.51
Burkitt's lymphoma cell line:RAJI	10476-106I8	76.16	71.97	41.22	12.58
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	98.49	60.12	31.02	10.23
CD133+ stem cells - cord blood derived, pool1	12223-129E9	124.10	41.37	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	11.27	5.64	4.51	0.00
CD14+ Monocytes, donor2	11305-117B9	6.50	4.08	3.53	1.48
CD14+ Monocytes, donor3	11381-118B4	9.00	3.95	3.51	2.41
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	30.57	12.17	7.08	2.26
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	23.50	11.37	6.44	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	27.94	10.85	8.55	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	8.82	5.93	3.04	2.75
CD14+ monocytes - mock treated, donor2	11873-125C1	6.34	4.83	5.73	2.41
CD14+ monocytes - mock treated, donor3	11883-125D2	8.53	4.03	3.08	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.86	3.52	3.01	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3.86	5.52	3.31	2.76
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	9.42	7.44	4.96	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	8.42	7.05	5.09	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	8.55	5.52	4.45	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	15.67	8.27	8.05	2.61
CD14+ monocytes - treated with Candida, donor1	11868-125B5	10.07	7.26	4.21	2.81
CD14+ monocytes - treated with Candida, donor2	11878-125C6	8.45	7.39	5.81	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	12.20	8.87	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	10.11	5.80	3.42	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	6.98	5.59	4.59	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	14.16	8.12	5.20	2.08
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	7.78	6.18	2.97	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	9.50	5.66	3.85	1.36
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.98	5.67	4.36	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.61	4.84	4.03	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	9.60	4.36	3.31	1.74
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	9.68	5.05	5.47	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	8.63	6.80	3.67	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.34	6.69	5.64	2.11
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.26	10.97	4.83	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.85	10.64	3.49	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.81	5.58	7.06	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	13.15	9.05	9.05	2.37
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	8.19	10.24	6.55	3.28
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.03	8.81	5.56	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	14.62	12.53	8.12	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	40.32	9.81	8.28	4.14
CD14+CD16+ Monocytes, donor2	11801-124D1	39.04	9.93	10.16	4.16
CD14+CD16+ Monocytes, donor3	11912-125G4	42.02	12.56	14.30	4.77
CD14+CD16- Monocytes, donor1	11788-124B6	23.67	10.90	7.63	3.43
CD14+CD16- Monocytes, donor2	11799-124C8	26.72	9.95	8.21	3.67
CD14+CD16- Monocytes, donor3	11910-125G2	27.43	9.81	10.26	4.24
CD14-CD16+ Monocytes, donor1	11790-124B8	36.23	15.06	8.68	3.57
CD14-CD16+ Monocytes, donor2	11800-124C9	31.84	15.15	11.86	2.85
CD14-CD16+ Monocytes, donor3	11911-125G3	43.79	14.11	10.95	2.95
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	16.26	16.26	8.13	8.13
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	29.15	12.20	14.92	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	32.10	22.78	16.57	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	19.72	15.46	12.26	3.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	27.88	23.05	19.30	4.82
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	25.97	24.57	11.93	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	32.16	20.39	18.04	6.27
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	39.55	30.32	19.77	3.95
CD19+ B Cells, donor1	11544-120B5	11.51	13.15	13.15	2.47
CD19+ B Cells, donor2	11624-122B4	7.98	12.33	8.71	1.45
CD19+ B Cells, donor3	11705-123B4	14.14	7.57	13.13	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	74.35	89.70	34.75	19.80
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	59.52	71.11	32.76	15.58
CD34+ Progenitors, donor1	11545-120B6	34.14	9.04	10.04	3.01
CD34+ Progenitors, donor2	11625-122B5	27.53	17.42	14.61	5.62
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	83.04	43.59	25.93	12.78
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	107.33	71.70	27.73	16.01
CD4+ T Cells, donor1	11225-116C1	20.35	10.71	17.14	3.93
CD4+ T Cells, donor2	11306-117C1	17.15	10.41	14.70	2.45
CD4+ T Cells, donor3	11382-118B5	24.09	8.23	6.71	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	62.28	18.89	8.68	4.34
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	63.56	22.68	9.66	8.09
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	48.58	16.39	10.06	5.46
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	26.08	12.33	14.70	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	37.93	23.88	16.15	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	9.89	19.78	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	66.91	18.93	5.49	6.21
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	51.01	18.98	7.12	7.12
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	53.52	23.21	6.93	6.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	60.52	30.93	10.76	6.28
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	83.15	37.73	14.32	8.39
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	68.64	24.64	15.84	6.16
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	61.56	14.34	6.32	4.22
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	48.41	17.24	7.06	6.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	47.78	13.37	9.36	5.35
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	19.58	15.77	10.88	3.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	23.05	11.25	15.54	3.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	14.35	16.14	12.55	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	78.99	26.52	10.75	10.75
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	65.64	25.56	4.77	9.10
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	58.21	17.23	6.30	6.72
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	33.88	26.80	8.60	4.55
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	40.29	19.06	10.83	5.63
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	44.45	10.02	8.72	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	48.00	28.70	10.39	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	42.47	25.85	15.69	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	55.83	19.54	12.56	8.37
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	37.66	23.54	10.52	4.43
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	43.92	28.22	13.25	4.17
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	26.18	12.32	4.62	7.70
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	44.41	22.56	9.31	5.01
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	42.93	13.85	16.62	2.77
CD8+ T Cells, donor1	11226-116C2	22.92	8.84	9.49	0.65
CD8+ T Cells, donor2	11307-117C2	17.65	6.38	6.38	1.13
CD8+ T Cells, donor3	11383-118B6	15.91	13.89	8.58	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	20.65	22.25	24.54	5.05
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	20.37	18.21	23.48	3.12
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	20.25	19.15	21.34	2.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	19.81	23.72	31.52	6.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	14.88	20.16	22.56	2.40
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.46	20.01	23.65	5.46
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	24.12	26.51	28.68	4.56
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.69	27.11	22.37	6.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.98	27.67	30.96	5.86
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	28.68	27.77	22.04	4.53
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.89	19.75	18.30	4.07
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	26.38	21.85	21.05	2.40
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	12.69	20.14	12.26	2.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	13.66	15.94	16.40	3.64
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	12.68	13.43	11.19	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	19.81	15.85	22.69	1.80
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	21.29	19.57	23.59	2.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.32	14.85	17.44	2.83
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	29.16	29.16	29.16	3.49
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.07	25.53	33.52	3.08
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.36	31.10	28.53	2.24
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	26.77	23.71	24.48	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	24.04	15.76	20.49	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.91	22.69	21.18	3.78
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.83	21.68	8.83	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	9.09	20.98	15.39	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	9.02	18.03	6.01	2.00
Cardiac Myocyte, donor1	11525-119I4	12.79	1.83	7.31	0.00
Cardiac Myocyte, donor2	11605-120I3	21.74	13.83	5.93	2.47
Cardiac Myocyte, donor3	11686-122I3	18.94	22.41	15.47	1.89
Chondrocyte - de diff, donor1	11261-116G1	14.21	18.03	13.17	1.73
Chondrocyte - de diff, donor2	11338-117F6	4.26	3.91	6.75	1.42
Chondrocyte - de diff, donor3	11410-118E6	8.31	8.19	7.74	1.48
Chondrocyte - re diff, donor2	11339-117F7	13.43	15.22	3.58	5.37
Chondrocyte - re diff, donor3	11411-118E7	4.85	6.07	7.28	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	26.16	19.28	18.36	5.16
Ciliary Epithelial Cells, donor2	11323-117D9	16.46	12.83	11.54	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	16.02	16.11	12.48	3.19
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	13.85	41.91	37.41	1.65
Corneal Epithelial Cells, donor1	11526-119I5	8.12	8.34	12.74	1.76
Corneal Epithelial Cells, donor2	11606-120I4	10.24	7.96	14.79	2.28
Corneal Epithelial Cells, donor3	11687-122I4	9.46	9.20	12.01	2.56
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	20.47	13.21	13.70	2.15
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	24.29	17.03	13.25	2.52
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	34.51	13.80	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	15.55	12.20	14.47	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	7.17	9.22	7.17	2.39
Dendritic Cells - plasmacytoid, donor2	11309-117C4	13.06	7.18	9.79	3.92
Dendritic Cells - plasmacytoid, donor3	11385-118B8	8.71	8.23	6.78	3.87
Endothelial Cells - Aortic, donor0	11207-116A1	13.51	15.01	6.50	3.17
Endothelial Cells - Aortic, donor1	11263-116G3	9.98	11.74	8.21	3.52
Endothelial Cells - Aortic, donor2	11340-117F8	8.20	13.29	7.35	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	8.26	5.90	5.90	1.18
Endothelial Cells - Artery, donor1	11264-116G4	6.98	11.05	3.49	2.33
Endothelial Cells - Artery, donor2	11341-117F9	13.18	14.35	8.47	2.59
Endothelial Cells - Artery, donor3	11413-118E9	12.97	16.83	7.54	1.58
Endothelial Cells - Lymphatic, donor1	11236-116D3	12.19	9.97	8.20	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	15.82	10.35	9.43	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	19.73	8.74	7.05	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	7.43	8.32	5.94	3.27
Endothelial Cells - Microvascular, donor2	11342-117G1	7.81	8.85	6.77	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	6.10	3.97	3.83	1.84
Endothelial Cells - Thoracic, donor1	11266-116G6	24.81	26.81	12.80	2.80
Endothelial Cells - Thoracic, donor2	11343-117G2	4.19	4.72	3.67	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	57.65	32.30	13.79	5.72
Endothelial Cells - Umbilical vein, donor2	11324-117E1	17.16	14.99	6.95	1.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	24.67	18.07	7.94	1.59
Endothelial Cells - Vein, donor1	11267-116G7	12.51	11.38	2.28	2.28
Endothelial Cells - Vein, donor2	11344-117G3	7.68	7.68	2.79	1.40
Endothelial Cells - Vein, donor3	11416-118F3	13.50	15.86	9.42	3.93
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	4.95	1.65	1.65
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.64	9.04	12.95	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	8.32	8.32	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.03	9.03	7.80	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.27	3.72	4.16	1.75
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.21	10.40	7.37	2.06
Fibroblast - Aortic Adventitial, donor1	11245-116E3	16.01	19.28	9.82	3.64
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	8.60	11.19	10.51	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.96	7.91	7.59	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	5.53	7.11	6.85	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.60	13.95	10.63	4.32
Fibroblast - Cardiac, donor1	11268-116G8	10.43	18.15	9.07	0.91
Fibroblast - Cardiac, donor2	11345-117G4	3.03	8.34	6.82	0.76
Fibroblast - Cardiac, donor3	11417-118F4	5.05	7.57	5.36	0.47
Fibroblast - Cardiac, donor4	11452-119A3	18.79	11.21	5.46	2.42
Fibroblast - Cardiac, donor5	11456-119A7	17.51	15.23	7.23	3.68
Fibroblast - Cardiac, donor6	11460-119B2	21.83	22.59	9.10	3.94
Fibroblast - Choroid Plexus, donor1	11492-119E7	9.38	10.85	6.43	2.01
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.49	4.75	4.75	3.02
Fibroblast - Choroid Plexus, donor3	11653-122E6	23.44	23.44	7.32	7.32
Fibroblast - Conjunctival, donor1	11531-120A1	5.30	15.22	16.61	3.92
Fibroblast - Conjunctival, donor3	11692-122I9	16.62	8.14	2.71	3.05
Fibroblast - Dermal, donor1	11269-116G9	8.92	11.03	10.80	3.99
Fibroblast - Dermal, donor2	11346-117G5	11.79	16.51	12.26	2.83
Fibroblast - Dermal, donor3	11418-118F5	21.64	17.17	15.96	3.87
Fibroblast - Dermal, donor4	11450-119A1	26.68	29.84	15.49	3.96
Fibroblast - Dermal, donor5	11454-119A5	27.74	32.45	15.70	4.19
Fibroblast - Dermal, donor6	11458-119A9	33.30	38.33	17.70	6.50
Fibroblast - Gingival, donor1	11237-116D4	21.45	8.75	5.83	5.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	15.46	8.65	4.72	3.41
Fibroblast - Gingival, donor2	11318-117D4	32.42	17.53	9.36	4.74
Fibroblast - Gingival, donor3	11394-118C8	14.12	8.99	4.93	2.90
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	7.27	6.23	3.12	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	4.58	4.58	5.46	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	26.97	21.83	10.60	6.39
Fibroblast - Gingival, donor6 (control)	11922-125H5	28.40	13.66	8.52	6.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	5.29	2.12	1.06	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	19.16	10.53	8.92	4.97
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	29.73	10.64	5.86	5.05
Fibroblast - Gingival, donor8 (control)	11926-125H9	22.82	16.34	9.65	5.92
Fibroblast - Gingival, donor9 (control)	11927-125I1	6.75	5.28	3.67	1.91
Fibroblast - Lung, donor1	11270-116H1	5.44	9.52	2.72	2.72
Fibroblast - Lung, donor2	11347-117G6	13.43	16.41	7.46	1.49
Fibroblast - Lung, donor3	11419-118F6	14.14	20.68	9.29	4.64
Fibroblast - Lymphatic, donor1	11506-119G3	7.50	12.50	12.50	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	6.99	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.68	2.52	4.48	0.84
Fibroblast - Mammary, donor1	11540-120B1	19.08	27.61	13.40	2.44
Fibroblast - Mammary, donor2	11620-122A9	3.99	15.98	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	17.87	11.91	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	37.82	22.89	16.29	8.53
Fibroblast - Periodontal Ligament, donor2	11319-117D5	30.34	29.58	15.17	5.31
Fibroblast - Periodontal Ligament, donor3	11395-118C9	29.37	17.44	11.32	3.67
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8.78	7.63	9.16	1.91
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.83	9.72	6.75	2.43
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	6.49	5.57	4.75	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	29.18	23.99	14.70	3.76
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	13.82	17.88	11.18	2.84
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.69	12.03	10.02	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	20.95	10.67	5.14	5.14
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	13.10	12.30	10.12	3.18
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	8.17	9.59	10.12	1.42
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	18.92	16.75	15.77	2.17
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	11.43	12.34	12.64	3.01
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	21.48	20.62	14.03	3.45
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	7.09	9.62	10.63	1.77
Fibroblast - skin normal, donor1	11553-120C5	13.29	8.70	8.86	1.48
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	14.24	16.44	13.03	2.41
Fibroblast - skin normal, donor2	11561-120D4	17.58	14.57	12.26	3.01
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	12.69	16.32	16.32	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.58	12.43	10.69	1.49
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	10.77	5.64	12.82	2.22
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	7.88	10.84	5.91	3.94
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.53	17.26	12.68	2.77
Fibroblast - skin walker warburg, donor1	11554-120C6	24.96	17.04	14.68	4.22
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.98	12.55	7.37	2.98
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	376.72	177.28	44.32	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	7.84	3.49	16.56	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	15.08	6.93	7.45	3.12
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.52	8.07	7.81	3.12
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	14.56	7.41	8.18	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	24.50	11.48	7.66
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	24.88	29.35	19.78	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	30.81	46.50	21.11	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	12.68	17.92	15.99	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	14.38	17.58	13.93	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	20.01	35.86	14.66	7.73
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.16	18.77	11.90	3.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	9.13	11.74	12.07	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	28.30	46.88	29.19	6.19
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	42.26	41.83	21.48	5.94
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	28.57	28.32	18.96	6.40
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	35.73	37.07	23.91	7.79
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	22.05	27.75	18.09	3.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	33.50	35.99	22.70	5.40
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	32.94	33.75	18.09	7.93
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	15.74	17.34	13.01	3.65
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	20.80	21.80	14.57	3.36
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	16.83	19.67	9.84	2.84
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	13.89	18.02	19.80	3.55
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	25.27	24.16	16.69	2.86
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	20.11	17.87	12.51	3.57
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	13.91	11.69	21.78	3.83
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	21.54	19.85	21.21	3.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	28.29	22.17	20.22	5.05
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.11	10.72	25.18	2.81
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	14.00	8.20	19.30	2.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	18.37	16.38	21.58	2.43
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.96	19.22	24.63	4.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.56	15.31	22.87	5.10
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	11.55	15.47	18.77	3.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	15.56	13.49	22.83	1.84
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	20.01	17.18	21.85	4.34
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	7.05	9.26	16.97	2.87
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	13.16	12.18	21.65	2.21
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	15.07	17.02	22.53	3.08
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	8.34	8.66	11.55	2.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	11.65	12.98	22.08	2.37
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.29	18.51	24.83	3.64
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	8.21	12.77	18.85	3.04
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.98	11.92	18.71	1.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	11.64	17.34	20.42	3.29
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	7.86	9.82	18.52	2.81
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.39	6.57	11.85	1.48
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	23.00	9.63	17.11	2.67
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	14.69	9.64	16.52	3.21
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	15.29	11.27	15.03	2.85
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.89	13.55	17.62	4.34
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	9.77	7.74	13.27	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	8.77	7.68	16.89	2.85
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	11.90	12.89	12.89	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	15.70	9.37	14.25	2.90
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.12	9.48	12.91	4.04
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	9.40	8.39	10.42	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	50.76	64.50	35.23	10.95
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	40.06	33.28	19.11	6.93
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	49.92	55.65	25.16	10.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	54.14	83.24	38.49	13.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	62.44	81.38	46.06	18.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	43.35	54.42	32.28	11.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	54.45	17.32	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	31.72	38.68	25.53	8.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	35.30	24.07	38.51	17.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	41.73	36.52	20.87	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	34.50	41.66	16.92	4.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	39.12	32.53	17.30	9.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	39.99	29.99	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	31.32	31.88	19.85	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	33.34	32.68	15.69	6.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	25.17	36.07	23.49	14.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	28.31	34.35	23.54	7.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	31.93	36.00	21.74	6.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	58.47	43.85	27.15	10.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	26.34	33.22	26.92	10.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	11.84	22.49	14.21	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	50.82	32.19	16.94	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	30.24	28.99	18.64	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	30.15	33.14	22.55	4.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	52.68	15.81	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	23.06	23.45	18.07	5.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.49	28.36	18.58	5.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	24.08	34.78	14.71	5.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	16.57	33.52	23.50	8.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	19.86	31.50	21.23	7.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	32.30	29.82	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	16.51	28.31	21.71	8.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	21.73	30.78	24.14	4.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	16.28	29.50	22.89	9.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.14	27.52	26.32	6.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	12.33	30.09	17.76	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	22.43	44.86	43.68	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	16.92	26.26	20.42	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	9.22	24.14	13.61	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	7.63	17.80	30.52	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	10.74	23.28	26.26	4.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.01	19.90	18.92	4.37
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	7.99	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	4.99	2.49	9.15	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	4.50	5.62	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	7.29	5.39	4.44	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.85	5.85	3.76	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	49.67	32.26	47.35	6.50
Hep-2 cells mock treated, biol_rep2	11899-125E9	48.11	35.79	57.39	7.93
Hep-2 cells mock treated, biol_rep3	11900-125F1	40.95	33.44	56.65	12.06
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	50.94	29.73	55.86	11.04
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	37.61	31.38	55.66	11.61
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	38.54	35.31	51.45	11.19
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	50.31	30.01	49.32	10.09
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	38.08	28.48	44.95	9.78
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	42.29	33.00	58.31	9.93
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	7.28	13.99	2.24	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	11.25	8.22	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	13.22	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.35	8.82	5.29	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.91	10.17	2.91	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	19.58	14.34	7.87	3.15
Hepatocyte, donor1	11523-119I2	4.84	8.47	10.90	1.21
Hepatocyte, donor2	11603-120I1	9.70	6.46	9.70	1.08
Hepatocyte, donor3	11684-122I1	12.27	3.68	7.98	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	62.01	33.29	15.01	9.14
Intestinal epithelial cells (polarized), donor1	11246-116E4	25.17	26.74	13.63	3.15
Iris Pigment Epithelial Cells, donor1	11530-119I9	17.84	18.93	18.80	2.33
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	22.29	9.55	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	13.35	40.05	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	16.61	12.46	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	2.50	17.52	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	12.81	17.94	7.69
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	9.14	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	27.61	19.49	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	18.34	6.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	39.94	10.89	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	11.91	14.56	18.53	6.62
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	11.09	19.96	16.63	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	31.43	20.95	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	27.08	20.16	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	29.39	10.83	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	10.34	25.20	14.86	4.52
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	17.71	8.05	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	23.90	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	16.30	25.26	15.48	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.04	21.83	15.11	2.10
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	13.66	16.88	14.47	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	22.16	12.00	4.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	15.08	30.16
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.97	26.91	16.99	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	23.58	12.70	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	29.48	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	19.37	20.45	16.14	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2.54	11.43	8.89	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	16.43	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	7.65	14.67	12.12	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	9.11	21.87	12.76	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	47.41	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	8.57	17.14	10.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	36.50	19.91	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	10.80	24.38	14.20	3.70
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	24.58	10.54	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	18.86	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	6.26	17.38	11.13	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	13.28	6.64	8.85
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	16.21	25.94	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	5.23	14.82	7.85	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	6.75	6.75	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	31.36	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	12.80	8.53	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	15.24	6.93	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	25.65	5.70	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	13.81	11.05	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	15.13	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	12.42	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	3.17	5.29	3.17	1.06
Keratinocyte - epidermal, donor1	11272-116H3	9.71	5.14	10.04	1.63
Keratinocyte - epidermal, donor2	11349-117G8	7.03	5.86	7.61	1.17
Keratinocyte - epidermal, donor3	11421-118F8	30.38	14.39	21.49	5.49
Keratinocyte - oral, donor1	11251-116E9	38.82	20.55	27.36	3.52
Keratocytes, donor1	11527-119I6	6.53	15.13	15.82	1.72
Keratocytes, donor2	11607-120I5	7.03	16.41	8.20	3.52
Keratocytes, donor3	11688-122I5	5.34	9.09	9.68	2.96
Krukenberg tumor cell line:HSKTC	10687-109F3	8.79	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	21.57	19.42	18.34	3.24
Lens Epithelial Cells, donor2	11609-120I7	14.65	18.22	19.84	3.58
Lens Epithelial Cells, donor3	11690-122I7	7.97	7.87	8.78	1.92
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.15	9.60	10.32	1.78
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.09	8.65	5.86	2.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.96	9.29	8.19	2.68
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.29	7.53	6.45	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.35	8.51	3.78	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.58	5.18	6.04	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.26	11.90	8.21	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.80	5.56	4.55	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.45	6.33	6.62	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.47	8.70	7.52	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.80	11.83	7.76	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.33	2.96	4.26	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.41	10.10	8.71	2.79
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	12.16	9.06	7.87	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.42	5.22	6.32	1.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	14.17	11.09	9.24	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.92	4.68	4.36	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	4.94	5.49	5.31	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.18	7.90	7.57	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.32	6.44	5.56	1.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.73	2.74	2.99	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	13.58	11.64	8.73	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.77	11.58	7.54	1.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.84	6.21	5.15	1.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	13.48	10.37	7.78	3.11
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.08	11.52	9.42	2.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.07	5.86	6.92	1.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.01	11.69	8.94	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.42	9.78	6.96	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.85	4.98	5.09	1.06
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.54	10.18	9.21	2.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	10.59	9.26	7.28	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.58	4.96	4.58	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	13.33	7.40	7.77	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	16.31	11.12	9.64	2.47
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.52	4.26	3.99	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.87	9.33	9.65	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.52	9.13	10.65	3.35
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	10.36	8.40	9.24	2.24
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.44	9.60	8.53	3.20
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.70	6.30	7.76	1.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.80	3.89	4.36	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.82	7.52	7.16	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.84	6.21	7.19	2.29
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.53	4.71	3.06	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	11.88	9.53	8.17	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.68	5.89	6.40	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.86	6.27	4.18	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	38.52	20.39	11.33	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	28.38	15.34	18.41	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	23.75	11.88	17.81	5.20
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	28.35	18.62	14.81	4.65
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	19.69	9.85	12.66	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	14.01	16.81	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	21.13	12.88	18.55	3.61
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	15.46	16.65	8.33	9.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	35.74	21.04	19.00	7.69
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	36.94	18.03	21.52	7.56
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	29.71	17.56	23.41	4.05
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	32.79	18.29	19.65	6.23
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	31.84	14.89	20.54	4.62
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	31.05	21.88	24.70	5.65
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	33.98	17.99	21.99	8.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	36.17	14.77	21.90	5.09
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	34.42	20.81	22.68	6.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	29.29	17.76	20.41	5.48
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	29.45	14.73	18.41	6.75
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	38.32	17.94	18.75	9.79
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	31.03	13.74	18.53	5.41
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	28.31	17.38	19.62	5.32
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	34.00	13.39	25.76	6.18
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	29.90	18.58	19.45	4.35
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	33.78	19.43	24.81	2.99
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	34.30	26.00	19.36	4.98
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	32.87	14.85	21.21	4.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	24.71	16.60	22.13	5.90
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	18.42	10.36	28.78	9.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	26.86	18.80	19.57	5.37
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	31.14	12.45	19.81	5.66
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.15	29.54	21.33	3.28
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	35.70	22.14	24.40	4.52
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	25.85	9.34	25.85	5.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	33.61	25.39	23.90	6.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	24.15	23.41	19.32	4.83
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	28.86	16.80	27.14	3.88
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.12	18.84	18.84	7.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	23.99	19.66	19.32	5.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	19.31	10.26	21.72	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.77	19.91	17.77	5.69
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	22.00	13.40	17.87	4.81
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	25.23	12.35	22.54	5.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	18.85	12.12	16.16	4.71
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	28.15	18.15	19.63	6.30
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	56.98	23.26	23.26	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	25.39	8.46	10.58	7.40
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	25.61	14.01	22.01	6.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	21.81	16.72	4.36
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	31.43	14.56	20.70	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	32.06	13.81	20.72	4.44
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.05	15.05	18.82	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	27.15	18.10	18.10	6.03
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	27.49	14.87	26.59	8.11
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	22.37	17.21	15.49	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	26.28	18.70	20.93	4.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	26.59	14.86	22.29	7.82
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	27.05	15.17	24.41	5.28
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	28.02	23.35	20.24	4.15
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	38.51	15.75	20.57	4.38
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	31.87	16.77	24.04	4.47
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	30.47	17.67	20.32	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	32.01	18.51	20.06	5.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.79	16.20	19.75	4.56
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	20.19	19.71	22.59	7.69
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	31.01	15.11	19.88	5.96
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	21.27	15.19	29.17	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	23.52	14.53	14.53	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	26.22	17.48	15.58	6.84
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	27.37	16.01	25.82	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	25.40	22.37	30.23	4.23
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	26.94	17.75	19.01	6.34
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	25.06	17.59	28.25	9.06
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	31.61	20.69	25.86	3.45
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	26.23	15.43	26.74	6.17
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	24.05	15.56	19.81	7.78
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	27.81	20.43	14.75	5.67
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	30.37	15.39	26.21	7.07
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.01	11.75	32.89	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	18.79	19.62	20.46	7.10
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	26.48	17.66	20.44	6.04
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	25.42	14.72	25.42	4.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	31.54	31.01	29.94	6.42
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	34.75	22.23	20.20	4.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	34.87	23.86	25.70	5.51
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	32.01	29.34	24.01	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.35	22.79	19.38	3.42
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	23.01	22.24	33.74	3.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	31.19	32.83	27.36	4.92
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	21.83	18.71	29.84	4.90
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	34.31	27.04	38.21	4.94
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	35.14	23.87	23.21	6.63
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	10.39	35.34	6.24
Macrophage - monocyte derived, donor1	11232-116C8	27.81	11.62	9.34	3.19
Macrophage - monocyte derived, donor2	11313-117C8	13.03	7.52	17.07	0.37
Macrophage - monocyte derived, donor3	11389-118C3	23.59	10.62	10.62	1.57
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	14.34	7.43	6.37	1.59
Mallassez-derived cells, donor2	11929-125I3	17.75	6.65	6.34	0.95
Mallassez-derived cells, donor3	11930-125I4	32.11	15.15	15.15	2.64
Mammary Epithelial Cell, donor1	11273-116H4	40.46	28.30	33.38	5.58
Mammary Epithelial Cell, donor2	11350-117G9	38.22	27.80	38.80	5.50
Mammary Epithelial Cell, donor3	11422-118F9	10.23	12.72	14.72	2.99
Mast cell - stimulated, donor1	11487-119E2	55.59	40.68	22.37	6.78
Mast cell, donor1	11563-120D6	32.33	12.65	11.14	4.22
Mast cell, donor2	11565-120D8	6.54	6.54	10.40	2.97
Mast cell, donor3	11566-120D9	8.55	6.98	17.33	1.35
Mast cell, donor4	11567-120E1	10.28	5.85	13.47	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	24.29	17.08	28.50	3.44
Mast cell, expanded and stimulated, donor8	11942-126A7	37.94	16.34	25.68	3.50
Mast cell, expanded, donor5	11939-126A4	33.61	13.54	11.24	5.85
Mast cell, expanded, donor8	11941-126A6	36.15	11.21	7.03	5.52
Melanocyte - dark, donor1	11502-119F8	17.11	15.42	13.03	3.38
Melanocyte - dark, donor2	11582-120F7	19.38	14.54	5.88	3.11
Melanocyte - dark, donor3	11663-122F7	16.66	9.92	18.54	2.03
Melanocyte - light, donor1	11274-116H5	6.58	3.76	9.64	1.88
Melanocyte - light, donor2	11351-117H1	2.73	0.00	4.09	0.00
Melanocyte - light, donor3	11423-118G1	4.34	2.60	6.94	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	19.16	9.89	20.51	1.56
Melanocyte, donor2 (MC+2)	12739-135I3	13.72	4.84	20.17	2.15
Melanocyte, donor3 (MC+3)	12837-137B2	10.18	3.48	15.00	0.00
Meningeal Cells, donor1	11493-119E8	19.73	25.31	22.21	3.72
Meningeal Cells, donor2	11573-120E7	16.29	20.69	12.32	3.08
Meningeal Cells, donor3	11654-122E7	37.90	30.32	27.14	6.93
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	24.52	23.10	12.26	5.13
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	7.35	6.14	5.74	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	2.63	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	7.85	5.23	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	24.40	27.99	13.63	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	4.87	5.72	5.08	1.69
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	11.56	4.52	4.52	4.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.11	16.48	17.80	2.64
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	14.61	16.80	21.19	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.55	15.14	8.80	1.64
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.56	9.83	8.59	1.52
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1.12	6.69	5.20	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	22.63	14.34	8.82	2.50
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	1.78	2.97	2.08	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.17	5.76	12.17	2.56
Mesenchymal stem cells - adipose, donor0	11217-116B2	31.19	25.52	16.66	3.90
Mesenchymal stem cells - hepatic, donor0	11218-116B3	22.20	19.08	5.94	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	28.30	37.01	20.32	7.98
Mesothelial Cells, donor1	11247-116E5	5.30	6.89	6.63	0.27
Mesothelial Cells, donor2	12156-128G5	1.50	7.01	4.50	0.00
Mesothelial Cells, donor3	11402-118D7	6.36	4.62	4.84	0.94
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	2.70	1.35	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	10.10	6.65	10.10	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.24	4.71	8.24	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.85	3.10	6.82	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.16	4.98	8.92	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	8.76	8.01	8.51	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.98	1.86	6.05	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	8.33	4.67	6.91	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.92	5.15	9.90	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	5.31	7.08	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.22	6.84	9.50	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.82	7.85	7.64	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.92	0.92	9.21	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	6.86	7.15	7.45	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	1.68	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.79	7.78	7.53	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5.47	4.99	5.94	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.32	0.55	6.63	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.52	9.90	7.60	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	9.04	4.42	5.47	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	6.93	8.76	9.78	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	8.58	7.72	9.23	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.00	2.67	4.89	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	7.23	6.57	8.98	1.53
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.04	1.01	2.53	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	4.97	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.52	7.61	7.34	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	3.82	5.00	7.06	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	1.09	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.65	7.69	9.61	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.80	5.60	10.41	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	9.60	5.48	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	11.01	12.01	14.52	3.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	4.08	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	11.39	24.09	28.90	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.28	3.84	11.53	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.14	19.09	22.31	1.49
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.70	1.39	4.18	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	8.84	2.21	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	16.75	17.09	23.25	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.75	3.94	5.69	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.07	3.55	4.97	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	15.43	24.13	23.57	2.52
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.91	4.16	2.49	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.17	7.58	5.83	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.46	16.59	20.21	3.02
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.84	7.10	10.85	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	9.24	15.70	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5.12	3.98	8.54	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.19	8.29	9.95	1.24
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.03	17.62	17.88	2.07
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	5.58	4.72	5.58	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	4.45	5.72	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	10.68	11.21	9.61	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	10.18	8.08	8.08	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.65	6.22	6.07	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.74	14.33	19.43	2.23
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	6.86	6.63	7.52	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	4.17	4.55	6.07	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.91	14.49	15.06	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	11.80	9.59	8.60	1.97
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3.26	1.96	7.17	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.41	9.11	12.64	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	13.55	7.50	6.92	1.73
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	9.07	11.54	10.72	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.93	7.74	8.93	1.79
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	15.07	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	10.69	7.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	19.39	13.80	10.84	2.63
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	10.52	7.36	7.36	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	16.41	8.11	9.29	2.77
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.04	4.66	13.04	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	23.66	12.02	13.52	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	13.58	5.59	11.45	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.26	8.82	7.58	1.81
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.84	6.63	7.37	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.92	7.69	5.13	2.56
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	3.11	17.11	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	26.72	17.64	19.24	3.74
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	7.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	7.07	4.04	5.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	16.02	5.48	12.23	2.53
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	38.13	29.96	13.62	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	39.42	25.43	20.98	3.18
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	37.25	21.87	21.87	5.67
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	13.59	7.55	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	13.05	26.10	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	9.50	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	8.62	10.34	7.54	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	6.79	5.75	9.41	3.14
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.00	4.67	7.34	2.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.09	2.09	3.76	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	11.60	10.27	5.13	3.42
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	6.38	4.79	4.79	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	0.68	3.40	6.12	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	16.54	7.35	7.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.77	3.35	4.19	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	4.42	4.42	4.65	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.86	4.32	2.97	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	3.78	5.68	4.63	1.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	44.54	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	3.97	5.96	6.45	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	3.25	1.62	1.08	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	3.17	3.17	2.49	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	2.45	3.43	3.43	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	5.47	5.83	4.56	2.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	2.12	3.18	3.18	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	1.20	4.20	4.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	6.89	3.61	0.33	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	1.79	1.63	3.90	1.30
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	1.23	2.82	3.00	1.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	2.11	1.41	9.14	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	1.38	1.84	2.30	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	1.93	4.82	4.18	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.90	7.24	3.10	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	12.64	7.59	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	1.56	3.56	2.90	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	1.27	4.66	6.35	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	1.66	2.14	3.09	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	3.00	4.72	9.01	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	18.06	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	0.33	2.67	4.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	1.35	1.35	4.96	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	2.38	4.36	1.59	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	0.93	2.79	9.29	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	2.65	4.92	3.78	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	0.98	1.96	5.54	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	0.44	1.31	3.92	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	0.90	0.90	3.62	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	2.65	3.53	2.65	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	4.65	3.32	6.65	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2.48	4.46	3.47	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	0.38	1.53	4.98	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	2.72	2.42	4.23	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	1.99	2.87	4.42	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	0.68	3.39	7.45	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	20.44	10.22	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3.05	4.27	6.10	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	0.31	1.26	3.15	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	0.30	1.82	1.51	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	1.58	3.16	1.58	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	1.13	9.07	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	20.23	15.17	0.00
Myoblast, donor1	11241-116D8	11.80	12.55	12.30	2.24
Myoblast, donor2	11322-117D8	11.70	12.85	11.70	2.88
Myoblast, donor3	11398-118D3	14.97	15.13	18.50	4.20
NK T cell leukemia cell line:KHYG-1	10777-110G3	37.36	34.15	8.32	7.00
Natural Killer Cells, donor1	11230-116C6	20.30	10.15	13.84	4.00
Natural Killer Cells, donor2	11311-117C6	16.89	8.14	5.73	3.92
Natural Killer Cells, donor3	11387-118C1	14.17	9.94	8.10	2.58
Neural stem cells, donor1	11275-116H6	5.81	5.81	11.61	1.81
Neural stem cells, donor2	11352-117H2	5.78	15.41	9.63	1.93
Neurons, donor1	11494-119E9	14.79	20.48	25.03	2.28
Neurons, donor2	11574-120E8	5.72	11.45	14.09	2.64
Neurons, donor3	11655-122E8	7.40	26.31	32.06	0.82
Neutrophils, donor1	11233-116C9	17.63	6.50	0.00	0.93
Neutrophils, donor2	11314-117C9	2.90	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	14.66	4.89	3.05	3.67
Nucleus Pulposus Cell, donor1	11252-116F1	9.97	6.77	4.87	1.66
Nucleus Pulposus Cell, donor2	11409-118E5	9.77	9.44	2.93	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	5.62	11.63	8.22	1.20
Olfactory epithelial cells, donor1	11933-125I7	7.71	5.37	18.72	0.69
Olfactory epithelial cells, donor2	11934-125I8	12.45	7.96	13.75	2.03
Olfactory epithelial cells, donor3	11935-125I9	5.11	3.29	12.71	1.82
Olfactory epithelial cells, donor4	11936-126A1	8.67	9.45	13.73	2.92
Oligodendrocyte - precursors, donor1	11496-119F2	11.43	13.84	13.84	1.20
Osteoblast - differentiated, donor1	11276-116H7	2.98	4.68	7.02	1.49
Osteoblast - differentiated, donor2	11353-117H3	0.00	2.29	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	4.34	4.97	2.48	1.24
Osteoblast, donor1	11277-116H8	3.32	6.45	5.86	2.35
Osteoblast, donor2	11354-117H4	12.64	21.77	14.75	2.11
Osteoblast, donor3	11426-118G4	8.71	11.02	9.06	2.49
Pancreatic stromal cells, donor1	11249-116E7	29.57	15.25	8.17	5.05
Pericytes, donor1	11491-119E6	1.78	4.45	4.56	0.56
Pericytes, donor2	11571-120E5	2.49	4.30	5.21	1.58
Pericytes, donor3	11652-122E5	9.36	13.22	9.77	2.64
Perineurial Cells, donor1	11499-119F5	24.86	29.84	22.04	5.09
Perineurial Cells, donor2	11579-120F4	22.08	16.75	5.89	3.22
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	24.86	7.01	10.52	3.51
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	10.53	8.08	6.86	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	13.07	8.93	7.25	2.46
Placental Epithelial Cells, donor1	11278-116H9	2.87	5.26	6.46	0.96
Placental Epithelial Cells, donor2	11355-117H5	2.22	3.33	7.76	0.00
Placental Epithelial Cells, donor3	11427-118G5	2.75	2.94	4.91	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.48	4.11	3.80	0.95
Preadipocyte - breast, donor1	11467-119B9	4.69	3.94	5.82	1.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	4.44	6.79	5.35	0.91
Preadipocyte - breast, donor2	11328-117E5	5.40	2.93	3.15	0.68
Preadipocyte - omental, donor1	11468-119C1	5.75	4.69	6.61	1.17
Preadipocyte - omental, donor2	11329-117E6	9.17	4.80	5.67	0.87
Preadipocyte - omental, donor3	11403-118D8	5.01	5.30	7.16	0.57
Preadipocyte - perirenal, donor1	11469-119C2	2.95	7.87	2.95	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	9.21	8.60	8.29	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	30.46	27.45	23.37	5.31
Preadipocyte - subcutaneous, donor3	11428-118G6	24.01	21.63	17.03	3.92
Preadipocyte - visceral, donor1	11280-116I2	27.76	24.59	17.51	5.59
Preadipocyte - visceral, donor2	11357-117H7	18.87	13.81	13.81	5.06
Preadipocyte - visceral, donor3	11429-118G7	20.06	24.35	14.63	5.02
Prostate Epithelial Cells (polarized), donor1	11253-116F2	26.70	25.49	15.84	4.53
Prostate Epithelial Cells, donor2	11331-117E8	8.53	6.09	4.87	1.22
Prostate Epithelial Cells, donor3	11404-118D9	4.41	5.82	9.25	0.73
Prostate Stromal Cells, donor1	11254-116F3	17.09	18.68	13.21	3.19
Prostate Stromal Cells, donor2	11332-117E9	17.75	16.50	14.70	3.05
Prostate Stromal Cells, donor3	11405-118E1	7.92	5.94	3.44	1.56
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.49	14.96	9.85	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	20.03	20.31	16.01	2.98
Renal Epithelial Cells, donor1	11517-119H5	3.55	11.16	8.62	2.54
Renal Epithelial Cells, donor2	11597-120H4	5.69	5.69	7.82	1.42
Renal Epithelial Cells, donor3	11678-122H4	22.13	18.53	16.73	2.43
Renal Glomerular Endothelial Cells, donor1	11514-119H2	3.40	10.89	6.81	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.57	18.19	7.14	2.43
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.76	14.21	9.10	2.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	1.33	1.33	1.33
Renal Mesangial Cells, donor1	11518-119H6	5.94	9.90	8.14	2.64
Renal Mesangial Cells, donor2	11598-120H5	5.64	10.03	8.15	1.88
Renal Mesangial Cells, donor3	11679-122H5	3.33	4.44	4.99	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	22.28	22.82	16.64	4.56
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.07	10.54	8.01	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	10.80	13.69	7.33	1.93
Retinal Pigment Epithelial Cells, donor0	11215-116A9	10.37	21.52	15.82	1.81
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.54	6.25	8.53	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	11.32	9.26	5.15
Retinal Pigment Epithelial Cells, donor3	11689-122I6	3.26	8.28	14.80	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	15.90	11.63	8.15	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	17.87	17.87	13.40	3.57
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	24.77	20.36	15.96	4.95
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	12.18	19.72	12.76	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	15.34	36.93	17.81	4.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	11.52	26.22	14.70	4.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	23.31	38.70	24.09	6.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	20.34	40.93	24.56	6.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	16.78	31.23	18.53	3.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	20.57	30.28	15.95	5.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	12.60	32.31	14.65	5.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	14.67	25.72	14.67	4.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	17.20	33.51	17.56	5.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.20	36.87	18.36	4.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	14.38	24.47	11.38	3.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	16.15	30.98	14.60	8.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	9.18	27.91	13.76	5.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	12.11	24.13	14.25	3.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	29.69	36.45	23.86	5.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	10.35	25.48	11.41	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	15.87	26.57	14.21	4.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	19.67	32.46	16.80	4.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	11.53	27.55	14.42	4.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	11.77	23.27	18.50	3.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.01	25.12	15.38	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	10.58	25.71	13.31	4.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	12.88	29.43	13.49	4.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	17.06	29.95	15.45	5.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	17.22	34.91	19.11	7.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	12.70	25.40	16.07	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	22.45	28.76	15.20	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.97	33.38	17.00	6.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	11.28	21.46	16.81	4.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	12.32	27.99	11.70	5.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	13.73	32.17	16.02	4.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	11.41	18.56	10.05	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	15.23	25.83	15.04	4.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	15.13	28.71	16.85	7.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	12.48	16.73	13.03	2.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	22.49	27.09	14.94	4.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	11.76	25.91	12.10	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	13.76	29.30	11.69	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	11.20	16.26	12.79	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	8.71	25.44	15.62	4.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	14.05	26.19	15.24	5.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	16.12	28.82	15.72	5.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	17.14	30.14	13.28	6.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	12.58	29.35	13.28	8.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	11.48	19.95	14.20	5.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	14.56	30.47	13.71	5.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	32.02	33.19	20.96	8.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	13.99	35.90	12.78	7.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	21.10	35.87	17.78	6.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	12.21	20.81	11.99	3.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	20.97	27.26	20.97	7.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.29	24.80	13.46	4.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	11.10	20.06	12.17	4.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	12.62	21.03	12.02	4.21
Schwann Cells, donor1	11498-119F4	3.95	10.34	9.03	1.13
Schwann Cells, donor2	11578-120F3	20.41	17.01	27.22	6.80
Schwann Cells, donor3	11659-122F3	15.55	9.64	12.49	2.41
Sebocyte, donor1	11220-116B5	14.24	9.86	6.57	0.55
Sebocyte, donor2	11301-117B5	6.89	4.60	5.06	2.30
Sebocyte, donor3	11378-118B1	6.60	4.53	7.01	1.44
Sertoli Cells, donor1	11255-116F4	9.94	31.48	11.60	1.66
Sertoli Cells, donor2	11333-117F1	5.65	8.47	16.95	5.65
Skeletal Muscle Cells, donor1	11281-116I3	3.43	5.45	10.03	0.97
Skeletal Muscle Cells, donor2	11358-117H8	0.00	1.45	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	12.54	17.56	5.85	2.51
Skeletal Muscle Cells, donor4	11451-119A2	22.15	29.85	17.75	3.93
Skeletal Muscle Cells, donor5	11455-119A6	27.35	26.01	20.81	4.01
Skeletal Muscle Cells, donor6	11459-119B1	22.78	35.86	22.32	5.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	34.02	17.39	9.70	4.66
Skeletal Muscle Satellite Cells, donor2	11321-117D7	23.69	18.12	6.85	3.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	25.00	31.75	21.53	5.36
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	7.58	9.27	9.86	1.85
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3.62	7.96	7.96	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.99	5.50	3.16	1.38
Skin - palm, donor1	10286-104F7	2.69	0.00	18.80	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.94	7.35	4.18	1.44
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	8.18	11.45	16.36	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.54	7.79	7.79	1.43
Small Airway Epithelial Cells, donor1	11256-116F5	15.01	8.76	11.12	1.39
Small Airway Epithelial Cells, donor2	11334-117F2	4.64	5.91	6.61	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	30.45	18.82	19.66	3.38
Small Airway Epithelial Cells, donor3	11406-118E2	3.90	4.65	6.45	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.96	15.74	15.12	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	5.56	7.34	10.89	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	5.88	6.47	6.47	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.51	10.61	8.18	1.77
Smooth Muscle Cells - Aortic, donor2	11360-117I1	4.73	7.48	6.30	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	8.50	7.73	12.36	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	6.00	5.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	6.52	6.79	9.71	1.60
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	14.63	16.18	16.18	2.88
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	10.50	12.29	9.99	1.79
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	16.28	9.77	8.47	2.28
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	15.06	12.70	6.50	3.54
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.11	7.55	5.27	1.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.18	9.92	10.41	1.63
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	4.57	6.70	4.26	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.84	9.34	9.60	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	11.44	7.63	3.81
Smooth Muscle Cells - Colonic, donor1	11239-116D6	15.78	14.30	7.37	2.95
Smooth Muscle Cells - Colonic, donor2	11320-117D6	11.41	12.70	6.46	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.95	16.06	8.50	2.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	3.09	6.65	4.64	1.39
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	2.16	8.62	3.23	3.23
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.38	10.16	5.68	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.10	11.27	11.61	2.39
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	19.55	15.55	10.13	2.43
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	7.85	13.39	17.31	3.02
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	8.42	10.47	12.06	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	10.26	4.23	3.62
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	33.38	42.92	15.37	4.24
Smooth Muscle Cells - Prostate, donor1	11257-116F6	13.72	17.18	9.05	2.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	12.77	12.90	7.39	2.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.88	5.58	4.31	2.28
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	14.78	15.38	11.76	3.17
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.75	8.25	7.50	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	3.88	21.97	5.17	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	9.30	8.84	8.37	4.19
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	4.04	11.11	9.09	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.95	8.46	9.72	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.78	7.96	6.19	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	30.41	26.74	22.49	5.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	15.88	5.14	5.61	3.27
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.76	11.37	8.49	1.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	7.14	12.49	8.67	3.31
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.02	16.36	6.58	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	31.72	22.78	15.23	5.45
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	16.25	14.58	10.47	2.26
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	2.86	1.43	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.65	10.77	7.58	2.45
Smooth Muscle Cells - Uterine, donor1	11258-116F7	9.72	14.14	10.61	2.21
Smooth Muscle Cells - Uterine, donor3	11466-119B8	22.53	29.26	19.90	3.22
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	4.28	7.39	2.14	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.73	8.20	7.93	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.02	5.21	3.72	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.11	6.83	5.75	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	2.56	7.38	6.81	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.54	17.33	9.45	5.91
Smooth muscle cells - airway, control, donor1	11966-126D4	10.67	9.40	8.13	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	4.79	9.58	3.59	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	8.78	5.43	4.18	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	8.25	5.96	1.83	1.83
Synoviocyte, donor1	11291-117A4	9.26	12.46	13.80	1.35
Synoviocyte, donor2	11368-117I9	8.55	10.39	5.87	1.17
Synoviocyte, donor3	11440-118H9	6.26	2.46	3.80	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	10.36	18.22	5.00	3.57
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	5.95	13.87	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	5.09	8.80	4.86	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	14.48	10.18	10.82	2.80
Tracheal Epithelial Cells, donor2	11369-118A1	6.19	6.96	8.50	2.32
Tracheal Epithelial Cells, donor3	11441-118I1	4.01	9.74	4.01	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	17.72	12.18	7.14	1.35
Urethra, donor2	10319-105A4	0.00	1.80	5.40	0.00
Urothelial Cells, donor1	11520-119H8	6.11	9.56	13.02	1.06
Urothelial Cells, donor2	11600-120H7	6.01	4.81	6.81	1.20
Urothelial Cells, donor3	11681-122H7	6.88	4.13	7.11	0.92
Urothelial cells, donor0	11216-116B1	22.29	14.04	9.81	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	17.80	9.79	8.01	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	15.73	8.58	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	9.58	4.11	2.74	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	21.35	8.61	3.79	1.38
Whole blood (ribopure), donor090325, donation2	12177-128I8	17.43	8.13	9.88	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	14.58	9.37	4.16	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.03	12.85	8.26	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	15.52	6.39	0.91	1.83
Wilms' tumor cell line:G-401	10809-111A8	22.58	26.40	18.38	5.18
Wilms' tumor cell line:HFWT	10597-108E3	1.76	8.80	5.28	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	20.39	13.41	16.20	5.87
achilles tendon, donor2	10292-104G4	4.13	8.27	10.33	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	63.23	35.95	12.24	5.86
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	103.55	72.21	31.81	11.61
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	57.34	44.04	17.21	10.09
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	70.48	60.14	21.22	11.43
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	82.92	91.07	60.71	9.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	86.71	56.68	22.84	11.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	55.80	31.03	12.25	5.17
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	64.33	64.77	23.79	7.93
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	79.63	36.34	17.97	11.84
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	61.35	54.75	11.26	15.14
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	62.74	40.48	32.75	7.36
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	50.71	35.10	15.60
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	61.35	35.79	20.68	9.53
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	68.35	49.97	23.56	8.54
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	57.57	41.21	22.80	8.77
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	19.98	11.15	7.44	4.18
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	55.11	41.95	28.38	6.99
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	12.58	21.18	8.90	6.45
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	44.80	32.43	13.65	6.40
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	43.07	26.08	17.89	8.19
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	58.97	32.98	16.85	6.02
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	51.45	34.75	21.83	6.90
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	23.01	38.69	25.68	3.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	24.16	18.58	9.29	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	40.68	48.21	22.22	3.39
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	49.28	67.16	40.12	10.03
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	24.37	44.99	20.62	3.75
adenocarcinoma cell line:IM95m	10796-110I4	17.90	14.37	6.12	4.24
adipose tissue, adult, pool1	10010-101C1	7.14	6.67	8.22	0.47
adipose, donor1	10184-103D4	29.32	26.97	20.52	4.10
adipose, donor2	10185-103D5	6.08	19.06	32.44	1.62
adipose, donor3	10186-103D6	8.99	15.52	16.88	3.54
adipose, donor4	10187-103D7	13.00	22.54	13.87	6.07
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	19.10	55.71	82.70	9.78
adrenal gland, adult, pool1	10081-102A9	10.91	10.91	10.91	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	31.75	43.36	28.68	8.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	24.65	20.72	12.15	4.64
amniotic membrane cells, donor1	12235-129G3	6.26	2.78	11.82	0.93
amniotic membrane cells, donor2	12236-129G4	16.23	6.42	15.21	3.72
amniotic membrane cells, donor3	12237-129G5	2.06	5.01	10.90	0.29
amygdala - adult, donor10196	10167-103B5	16.60	49.80	112.65	3.56
amygdala, adult, donor10252	10151-102I7	6.69	18.25	44.41	1.42
amygdala, newborn, donor10223	10360-105E9	20.66	23.56	49.38	4.84
anaplastic carcinoma cell line:8305C	10428-106D5	11.97	11.71	10.31	2.80
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	47.21	70.82	29.12	10.15
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	14.36	26.72	31.73	3.34
aorta, adult, pool1	10052-101G7	6.47	6.47	14.91	2.75
appendix, adult	10189-103D9	14.75	13.97	8.93	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	25.80	29.92	18.23	4.82
artery, adult	10190-103E1	4.08	9.51	13.59	1.36
astrocytoma cell line:TM-31	10425-106D2	25.50	47.81	41.87	5.50
b cell line:RPMI1788	10427-106D4	23.20	39.26	32.12	7.58
basal cell carcinoma cell line:TE 354.T	10702-109G9	6.66	11.65	9.71	2.22
bile duct carcinoma cell line:HuCCT1	10432-106D9	55.47	64.00	44.46	10.92
bile duct carcinoma cell line:TFK-1	10496-107C1	4.52	7.20	1.67	1.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	36.35	29.64	11.18	5.59
bladder, adult, pool1	10011-101C2	7.50	9.99	13.47	1.20
blood, adult, pool1	10053-101G8	17.72	11.07	6.64	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	7.71	5.14	2.57	0.00
bone marrow, adult	10192-103E3	20.24	11.47	10.12	2.02
brain, adult, donor1	10084-102B3	20.50	25.63	67.65	0.00
brain, adult, pool1	10012-101C3	13.03	32.96	93.32	2.56
brain, fetal, pool1	10085-102B4	10.69	8.01	32.06	0.00
breast carcinoma cell line:MCF7	10482-107A5	9.91	6.61	15.86	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	30.33	14.48	33.95	5.49
breast, adult, donor1	10080-102A8	4.42	6.31	5.68	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	41.92	24.14	21.85	8.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	25.36	23.81	25.05	6.80
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	63.54	64.46	75.74	20.03
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	23.97	12.35	11.86	4.60
carcinoid cell line:NCI-H1770	10703-109H1	24.45	75.70	69.58	10.34
carcinoid cell line:NCI-H727	10735-110B6	7.11	5.69	5.69	1.75
carcinoid cell line:SK-PN-DW	10719-109I8	28.84	64.33	37.08	10.14
carcinosarcoma cell line:JHUCS-1	10642-109A3	30.34	30.08	28.75	9.05
caudate nucleus - adult, donor10196	10177-103C6	13.82	31.09	42.60	2.30
caudate nucleus, adult, donor10252	10164-103B2	9.04	18.41	28.95	1.17
caudate nucleus, adult, donor10258	10379-105H1	19.87	52.73	82.53	4.58
caudate nucleus, newborn, donor10223	10354-105E3	20.88	16.85	22.34	2.93
cerebellum - adult, donor10196	10173-103C2	0.00	23.31	128.18	0.00
cerebellum, adult, donor10252	10166-103B4	3.42	22.42	60.64	0.85
cerebellum, adult, pool1	10083-102B2	3.45	24.49	72.78	1.72
cerebellum, newborn, donor10223	10357-105E6	4.15	15.78	32.38	2.49
cerebral meninges, adult	10188-103D8	10.84	27.48	64.30	0.76
cerebrospinal fluid, donor2	10294-104G6	5.85	5.85	10.96	1.46
cervical cancer cell line:D98-AH2	10552-107I3	2.16	3.59	11.22	1.29
cervical cancer cell line:ME-180	10553-107I4	33.97	36.46	37.78	9.45
cervix, adult, pool1	10013-101C4	8.08	6.72	12.18	1.36
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	10.31	11.43	17.84	1.81
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	5.23	3.92	0.00
choriocarcinoma cell line:BeWo	10423-106C9	31.07	17.15	15.04	9.20
choriocarcinoma cell line:SCH	10785-110H2	23.29	15.03	8.75	5.42
choriocarcinoma cell line:T3M-3	10618-108G6	7.59	11.15	7.12	4.03
chorionic membrane cells, donor1	12238-129G6	16.53	7.41	5.98	1.71
chorionic membrane cells, donor2	12239-129G7	9.15	6.36	4.77	1.39
chorionic membrane cells, donor3	12240-129G8	16.48	8.24	2.75	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	77.75	32.31	17.17	7.07
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	58.59	36.50	20.17	7.88
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	32.52	17.95	9.29	2.96
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	40.32	57.27	41.60	11.30
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	32.65	50.31	48.38	8.22
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	31.15	51.72	36.45	7.94
chronic myelogenous leukemia cell line:K562	10454-106G4	26.21	41.52	26.50	6.48
chronic myelogenous leukemia cell line:KU812	10409-106B4	39.09	51.60	21.11	5.73
clear cell carcinoma cell line:JHOC-5	10638-108I8	20.80	26.74	45.72	7.77
clear cell carcinoma cell line:TEN	10636-108I6	23.08	24.64	16.31	5.38
colon carcinoma cell line:CACO-2	10513-107D9	44.66	35.33	20.32	6.77
colon carcinoma cell line:COLO-320	10420-106C6	57.77	72.60	49.41	12.16
colon, adult, donor1	10082-102B1	17.85	10.71	7.14	1.19
colon, adult, pool1	10014-101C5	8.81	8.34	5.29	2.00
colon, fetal, donor1	10070-101I7	6.18	9.27	9.27	0.62
common myeloid progenitor CMP, donor1	12130-128D6	22.92	32.08	22.92	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	75.11	50.07	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	38.24	45.89	22.10	4.67
cord blood derived cell line:COBL-a 24h infection	10453-106G3	51.47	36.07	29.88	5.89
cord blood derived cell line:COBL-a untreated	10449-106F8	57.11	34.41	32.57	7.47
corpus callosum, adult, pool1	10042-101F6	5.86	10.61	16.58	0.66
cruciate ligament, donor2	10295-104G7	4.86	8.10	7.29	1.62
diaphragm, fetal, donor1	10069-101I6	4.01	4.82	11.24	0.00
diencephalon, adult	10193-103E4	9.84	18.48	28.80	2.16
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	84.73	72.79	40.41	11.71
ductal cell carcinoma cell line:KLM-1	10438-106E6	16.93	15.13	25.90	4.36
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	29.13	34.66	36.83	3.61
ductus deferens, adult	10196-103E7	21.93	9.97	9.47	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	7.20	15.84	15.84	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	16.18	10.30	9.56	0.00
dura mater, adult, donor1	10041-101F5	20.07	11.98	20.15	3.55
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	29.76	79.50	17.77	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	67.78	86.26	33.67	9.31
embryonic pancreas cell line:1B2C6	10604-108F1	3.08	3.70	13.57	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	1.82	5.75	9.38	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	3.40	4.32	9.57	0.62
embryonic pancreas cell line:2C6	10603-108E9	6.57	3.94	6.57	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	15.75	21.12	23.46	3.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	11.96	15.04	24.10	3.62
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	7.72	10.13	15.44	2.09
epidermoid carcinoma cell line:A431	10426-106D3	28.23	17.34	15.90	3.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	63.46	55.32	50.92	12.76
epididymis, adult	10197-103E8	20.93	12.98	11.93	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	18.45	23.06	23.77	4.26
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	20.84	14.94	7.86	3.54
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	48.23	47.31	42.85	11.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	44.29	36.61	30.61	9.25
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	50.41	49.74	42.68	11.88
esophagus, adult, pool1	10015-101C6	9.45	4.46	9.77	2.12
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	15.78	22.42	34.19	3.38
eye - muscle inferior rectus, donor1	10272-104E2	4.83	9.66	21.73	2.41
eye - muscle lateral, donor2	10298-104H1	6.31	2.10	14.73	0.00
eye - muscle medial, donor2	10299-104H2	2.98	5.95	14.88	0.00
eye - muscle superior, donor2	10297-104G9	11.46	4.59	24.08	0.00
eye - vitreous humor, donor1	10268-104D7	21.86	10.20	17.49	1.46
eye, fetal, donor1	10054-101G9	8.14	21.86	24.66	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	23.08	34.75	24.11	5.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	20.89	25.88	13.30	4.51
frontal lobe, adult, pool1	10040-101F4	19.70	45.41	120.00	3.10
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	52.84	25.22	39.93	6.91
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	22.68	12.16	12.80	2.74
gall bladder, adult	10198-103E9	9.42	7.73	7.73	0.97
gamma delta positive T cells, donor1	11937-126A2	25.23	15.57	12.88	2.68
gamma delta positive T cells, donor2	11938-126A3	23.16	17.55	7.10	5.60
gastric adenocarcinoma cell line:MKN1	10614-108G2	18.59	19.22	20.49	2.32
gastric adenocarcinoma cell line:MKN45	10612-108F9	15.09	15.28	13.54	2.13
gastric cancer cell line:AZ521	10549-107H9	33.12	65.42	28.36	8.36
gastric cancer cell line:GSS	10560-108A2	6.41	24.71	27.46	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	12.34	40.89	29.70	2.28
giant cell carcinoma cell line:LU65	10487-107B1	5.28	17.90	20.08	1.72
giant cell carcinoma cell line:Lu99B	10433-106E1	9.94	11.48	13.86	2.80
glassy cell carcinoma cell line:HOKUG	10688-109F4	18.96	11.97	12.22	2.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	7.07	5.91	5.07	2.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	6.74	9.55	4.92	1.26
glioblastoma cell line:T98G	10485-107A8	36.53	18.98	23.62	5.52
glioma cell line:GI-1	10413-106B8	12.59	13.77	4.69	2.93
globus pallidus - adult, donor10196	10175-103C4	10.20	21.14	37.17	2.19
globus pallidus, adult, donor10252	10161-103A8	8.54	10.01	13.43	1.22
globus pallidus, adult, donor10258	10367-105F7	2.74	4.11	10.95	1.37
globus pallidus, newborn, donor10223	10364-105F4	12.26	15.45	12.79	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	24.47	26.92	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	21.86	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	41.81	36.59	10.45
granulosa cell tumor cell line:KGN	10624-108H3	8.96	13.44	12.80	0.96
hIPS +CCl2, biol_rep1	14383-156B9	57.39	69.79	39.48	10.10
hIPS +CCl2, biol_rep2	14384-156C1	44.81	53.04	38.41	9.60
hIPS +CCl2, biol_rep3	14385-156C2	52.17	68.92	43.15	13.53
hIPS, biol_rep1	14380-156B6	58.93	44.56	80.49	15.81
hIPS, biol_rep2	14381-156B7	43.21	69.27	42.52	13.03
hIPS, biol_rep3	14382-156B8	17.66	35.31	61.79	2.21
hairy cell leukemia cell line:Mo	10712-109I1	23.27	36.49	42.53	5.75
heart - mitral valve, adult	10205-103F7	7.18	5.08	7.47	0.60
heart - pulmonic valve, adult	10206-103F8	3.66	5.49	13.07	0.26
heart - tricuspid valve, adult	10207-103F9	11.66	16.65	14.15	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	6.73	10.41	16.73	1.02
heart, adult, diseased, donor1	10051-101G6	4.68	7.66	15.76	1.28
heart, adult, pool1	10016-101C7	4.83	5.98	9.66	1.61
heart, fetal, pool1	10046-101G1	10.37	12.63	16.84	1.03
hepatic mesenchymal tumor cell line:LI90	10778-110G4	6.79	10.18	8.33	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	3.57	11.89	7.14	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	8.29	21.22	22.32	2.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	9.47	24.27	22.33	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	11.82	21.83	23.14	3.94
hepatoma cell line:Li-7	10484-107A7	12.79	25.47	12.46	3.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	43.32	63.21	25.23	10.15
hippocampus - adult, donor10196	10169-103B7	21.77	41.64	52.99	6.62
hippocampus, adult, donor10252	10153-102I9	6.74	12.04	25.10	0.41
hippocampus, adult, donor10258	10374-105G5	14.44	40.83	144.90	1.00
hippocampus, newborn, donor10223	10363-105F3	14.45	19.03	28.90	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	40.28	51.88	29.91	13.43
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	20.03	31.02	16.89	8.64
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	23.61	37.83	19.55	7.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	14.66	10.71	11.84	5.64
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	10.59	13.17	11.36	3.61
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	15.56	16.32	14.43	6.07
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	12.26	15.77	14.31	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	9.48	21.33	22.84	2.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.01	15.01	13.35	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	13.02	15.63	15.87	3.79
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	11.73	16.88	15.11	2.73
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	14.81	25.59	23.57	4.71
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	18.62	31.77	12.83	6.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	13.76	38.81	14.25	4.91
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	39.27	52.37	30.55	7.85
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	11.45	14.32	12.60	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	13.95	11.34	8.72	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	16.49	19.99	8.00	5.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	9.04	17.33	31.27	3.96
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	8.64	24.10	44.11	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	7.83	19.73	44.79	4.70
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	8.00	13.72	21.88	2.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.58	16.84	24.68	3.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.96	12.55	20.03	2.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	20.69	33.44	15.70	6.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	15.12	40.51	16.26	7.13
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	35.11	60.84	25.32	8.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	11.27	13.38	14.08	3.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	10.45	16.47	9.50	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	14.83	15.74	9.08	3.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	8.27	16.03	26.89	3.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	13.28	15.28	27.89	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.44	12.06	14.37	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.97	14.83	11.50	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	14.39	11.36	28.77	6.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.07	10.42	14.11	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	15.94	29.46	16.18	5.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	24.96	33.87	17.83	8.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	28.29	40.00	24.88	7.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	10.09	11.92	11.31	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	35.79	81.33	32.53	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	18.53	20.52	13.90	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	10.40	15.32	24.08	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	7.60	17.01	18.46	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	6.41	16.73	20.28	3.91
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	5.97	19.09	11.93	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	12.87	21.53	16.52	4.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	11.85	14.28	10.78	3.50
immature langerhans cells, donor1	11904-125F5	55.45	24.46	33.90	7.02
immature langerhans cells, donor2	11905-125F6	37.23	26.93	31.69	3.96
insula, adult, pool1	10039-101F3	26.50	44.76	122.55	3.69
keratoacanthoma cell line:HKA-1	10791-110H8	8.45	7.48	20.16	3.90
kidney, adult, pool1	10017-101C8	24.23	13.12	17.22	2.00
kidney, fetal, pool1	10045-101F9	8.13	14.57	20.94	1.06
large cell lung carcinoma cell line:IA-LM	10509-107D5	27.55	41.04	37.64	5.40
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.86	20.18	19.35	4.98
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.46	11.74	12.11	3.12
left atrium, adult, donor1	10079-102A7	7.08	9.26	9.81	2.72
left ventricle, adult, donor1	10078-102A6	6.07	8.09	13.65	0.51
leiomyoblastoma cell line:G-402	10721-110A1	8.21	18.06	13.41	2.46
leiomyoma cell line:10964C	10569-108B2	5.03	7.90	10.06	1.80
leiomyoma cell line:15242A	10570-108B3	5.43	8.15	13.04	2.72
leiomyoma cell line:15425	10571-108B4	11.90	10.93	12.38	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	6.35	19.05	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	31.37	19.87	7.32	4.18
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	24.20	53.48	23.38	4.25
liposarcoma cell line:KMLS-1	10782-110G8	22.96	20.93	17.50	4.06
liposarcoma cell line:SW 872	10726-110A6	39.23	29.36	37.40	6.09
liver, adult, pool1	10018-101C9	10.21	13.78	10.05	1.30
liver, fetal, pool1	10086-102B5	7.53	10.35	2.82	1.88
locus coeruleus - adult, donor10196	10182-103D2	4.52	16.48	45.79	1.17
locus coeruleus, adult, donor10252	10165-103B3	6.83	20.30	28.42	1.11
locus coeruleus, adult, donor10258	10375-105G6	9.03	18.34	45.42	3.10
locus coeruleus, newborn, donor10223	10362-105F2	15.98	20.61	25.66	0.84
lung adenocarcinoma cell line:A549	10499-107C4	6.23	8.30	16.61	2.21
lung adenocarcinoma cell line:PC-14	10408-106B3	12.41	4.83	5.52	3.45
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	22.80	16.35	18.45	3.30
lung, adult, pool1	10019-101D1	10.16	7.68	8.86	1.06
lung, fetal, donor1	10068-101I5	10.56	9.70	13.98	1.14
lung, right lower lobe, adult, donor1	10075-102A3	15.12	7.79	3.67	2.75
lymph node, adult, donor1	10077-102A5	14.20	17.51	6.15	2.37
lymphangiectasia cell line:DS-1	10727-110A7	10.08	27.40	15.78	4.38
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	170.70	128.74	68.67	21.58
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	9.34	13.59	15.29	0.85
mature adipocyte, donor1	12231-129F8	2.22	4.00	7.10	0.00
mature adipocyte, donor2	12232-129F9	3.11	4.77	8.51	0.62
mature adipocyte, donor3	12233-129G1	2.37	4.50	5.69	0.71
mature adipocyte, donor4	12234-129G2	3.42	2.63	5.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	9.77	25.73	37.17	2.14
medial frontal gyrus - adult, donor10196	10170-103B8	23.69	64.30	141.00	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	8.64	20.23	61.06	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	21.92	46.38	145.18	2.54
medial frontal gyrus, newborn, donor10223	10352-105E1	51.18	45.63	68.66	5.12
medial temporal gyrus - adult, donor10196	10183-103D3	22.61	45.56	114.24	3.88
medial temporal gyrus, adult, donor10252	10156-103A3	5.94	20.59	56.45	1.70
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	25.04	40.45	236.93	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	43.06	244.01	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	23.33	33.02	62.10	4.31
medulla oblongata - adult, donor10196	10174-103C3	4.54	15.58	25.31	1.30
medulla oblongata, adult, donor10252	10155-103A2	6.19	14.24	21.52	1.70
medulla oblongata, adult, pool1	10038-101F2	7.75	17.22	34.61	1.31
medulla oblongata, newborn, donor10223	10361-105F1	6.25	9.03	18.75	1.39
medulloblastoma cell line:D283 Med	10838-111E1	15.06	28.12	25.91	2.44
medulloblastoma cell line:ONS-76	10759-110E3	13.21	22.25	18.95	3.30
melanoma cell line:COLO 679	10514-107E1	10.92	7.76	16.82	1.58
melanoma cell line:G-361	10465-106H6	13.03	9.77	26.87	1.36
meningioma cell line:HKBMM	10691-109F7	26.23	28.22	16.46	2.17
merkel cell carcinoma cell line:MKL-1	10843-111E6	26.43	26.43	36.13	12.34
merkel cell carcinoma cell line:MS-1	10844-111E7	18.40	13.74	17.11	4.41
mesenchymal precursor cell - adipose, donor1	11747-123G1	23.94	27.93	15.80	3.22
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.36	17.27	7.45	2.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.42	16.56	13.67	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.43	8.57	5.20	1.83
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	4.43	12.13	5.58	2.70
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	4.16	9.02	10.41	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.21	8.92	4.81	2.06
mesenchymal precursor cell - cardiac, donor2	11753-123G7	9.78	10.58	7.59	1.84
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.98	15.65	6.63	3.45
mesenchymal precursor cell - cardiac, donor4	11755-123G9	15.39	16.74	9.18	3.92
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	14.80	17.78	8.82	2.99
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	7.25	4.61	6.59	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	20.62	17.71	10.79	2.21
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	17.11	15.71	16.06	3.49
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.47	16.33	12.45	2.86
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.50	9.35	5.03	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.66	9.21	7.24	1.14
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.07	6.16	4.56	1.82
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	23.91	36.92	28.95	4.20
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	12.25	14.50	8.22	2.54
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	12.52	11.20	6.30	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	10.31	9.57	8.47	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.30	13.16	8.30	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	32.84	30.31	17.68	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.05	7.76	9.59	2.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	11.00	10.23	7.16	3.07
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.83	9.68	7.07	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.63	8.01	8.32	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	10.83	8.24	6.59	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.82	10.49	7.45	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.43	10.22	4.72	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	10.66	14.36	6.49	4.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	17.31	11.54	6.06	4.04
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	13.61	8.25	6.25	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.55	9.61	8.41	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	11.00	11.73	13.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.40	8.39	8.39	5.71
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	10.23	11.05	6.55	3.28
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.75	7.73	9.02	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	5.47	5.47	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	25.82	10.33	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.39	9.42	9.09	2.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	13.09	10.18	5.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	13.33	14.93	7.46	4.80
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.08	12.27	13.08	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.22	8.55	9.33	3.50
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	16.79	14.69	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	9.93	7.95	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	4.77	14.30	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.89	13.05	11.86	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	13.40	12.18	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	9.50	15.83	8.23	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	5.52	12.42	4.83	3.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	8.60	8.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	7.98	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	10.33	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.11	3.67	4.07	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	5.56	2.38	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2.36	4.72	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	5.92	6.23	4.36	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	1.34	12.03	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	9.46	5.91	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	17.98	15.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.08	11.01	8.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	15.83	5.44	4.95	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	3.36	4.49	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.09	12.09	3.82	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	11.69	4.43	7.25	3.22
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	10.90	6.54	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	0.00	2.53	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	5.46	4.25	2.43	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.06	5.77	4.12	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.53	4.56	5.95	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.46	2.92	5.84	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	3.06	3.06	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	4.64	3.87	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	9.69	21.26	23.39	4.96
mesothelioma cell line:ACC-MESO-4	10494-107B8	4.40	6.02	12.51	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	38.46	21.37	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	43.67	32.16	18.08	4.11
mesothelioma cell line:Mero-25	10850-111F4	11.35	20.88	17.70	1.82
mesothelioma cell line:Mero-41	10851-111F5	51.83	17.36	21.02	6.60
mesothelioma cell line:Mero-48a	10852-111F6	25.02	16.83	13.06	4.87
mesothelioma cell line:Mero-82	10853-111F7	25.23	22.60	17.08	3.94
mesothelioma cell line:Mero-83	10854-111F8	18.38	15.15	13.79	4.09
mesothelioma cell line:Mero-84	10855-111F9	16.43	14.66	22.75	1.77
mesothelioma cell line:Mero-95	10856-111G1	19.25	10.56	15.11	2.07
mesothelioma cell line:NCI-H2052	10847-111F1	41.41	39.42	15.90	4.47
mesothelioma cell line:NCI-H226	10846-111E9	32.40	25.16	9.77	4.16
mesothelioma cell line:NCI-H2452	10848-111F2	41.00	23.92	14.52	6.15
mesothelioma cell line:NCI-H28	10845-111E8	36.13	43.77	46.57	12.21
mesothelioma cell line:No36	10857-111G2	27.73	34.90	27.07	5.87
mesothelioma cell line:ONE58	10858-111G3	31.70	21.13	14.09	3.79
migratory langerhans cells, donor1	11901-125F2	35.31	19.58	20.15	2.88
migratory langerhans cells, donor2	11902-125F3	24.67	21.61	11.36	1.47
migratory langerhans cells, donor3	11903-125F4	38.05	25.13	24.59	4.31
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.00	25.47	25.47	3.92
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	20.35	38.36	25.64	4.03
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	8.29	17.97	10.83	3.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	27.02	28.73	31.40	5.90
myelodysplastic syndrome cell line:SKM-1	10772-110F7	69.30	75.40	34.56	17.19
myeloma cell line:PCM6	10474-106I6	7.31	8.10	5.93	2.37
myxofibrosarcoma cell line:MFH-ino	10600-108E6	8.12	7.61	33.99	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	21.38	24.32	9.02	3.92
nasal epithelial cells, donor1, tech_rep1	12226-129F3	3.57	6.35	7.80	0.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	4.71	5.81	9.56	0.96
nasal epithelial cells, donor2	12227-129F4	9.38	6.62	16.01	2.21
neuroblastoma cell line:CHP-134	10508-107D4	13.57	28.07	38.88	7.13
neuroblastoma cell line:NB-1	10539-107G8	27.31	77.83	52.38	8.04
neuroblastoma cell line:NBsusSR	10607-108F4	3.80	12.02	5.90	1.05
neuroblastoma cell line:NH-12	10555-107I6	8.57	32.24	74.35	6.52
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	5.46	18.27	6.17	4.98
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	11.88	23.28	16.31	4.28
neuroectodermal tumor cell line:TASK1	10774-110F9	26.97	56.96	22.54	11.47
neuroepithelioma cell line:SK-N-MC	10728-110A8	9.54	8.90	4.45	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	10.91	11.71	9.85	1.06
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	55.98	33.99	31.46	10.65
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	44.03	64.84	71.25	6.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	11.54	8.34	9.30	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	10.77	6.57	5.52	1.84
nucleus accumbens, adult, pool1	10037-101F1	21.93	38.06	85.58	2.44
occipital cortex - adult, donor10196	10172-103C1	12.36	45.33	156.59	0.00
occipital cortex, adult, donor10252	10163-103B1	6.44	15.03	48.04	0.81
occipital cortex, newborn, donor10223	10355-105E4	21.11	26.57	57.14	4.00
occipital lobe, adult, donor1	10076-102A4	16.01	52.22	122.54	4.99
occipital lobe, fetal, donor1	10073-102A1	11.59	19.74	39.05	4.29
occipital pole, adult, pool1	10036-101E9	8.36	34.69	96.27	2.05
olfactory region, adult	10195-103E6	10.32	29.42	75.85	1.34
optic nerve, donor1	10277-104E7	4.00	14.01	36.02	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	18.00	19.02	9.91	4.10
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	29.95	38.47	38.19	6.59
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	21.00	12.70	24.55	4.57
oral squamous cell carcinoma cell line:SAS	10544-107H4	34.77	33.04	28.07	6.58
osteoclastoma cell line:Hs 706.T	10704-109H2	6.47	8.23	8.23	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	21.49	22.42	21.49	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	8.91	18.24	6.15	2.76
ovary, adult, pool1	10020-101D2	7.86	15.20	13.19	1.92
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	20.72	37.76	26.58	3.48
pancreas, adult, donor1	10049-101G4	15.99	17.87	18.81	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	39.97	15.09	3.35	9.78
papillary adenocarcinoma cell line:8505C	10437-106E5	35.26	21.46	19.76	4.60
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	12.92	23.51	10.76	3.48
paracentral gyrus, adult, pool1	10035-101E8	17.57	46.40	121.91	3.39
parietal cortex, adult, donor10258	10373-105G4	15.41	33.03	73.40	0.73
parietal lobe - adult, donor10196	10171-103B9	8.46	27.27	98.75	4.70
parietal lobe, adult, donor10252	10157-103A4	5.99	22.52	69.83	0.86
parietal lobe, adult, pool1	10034-101E7	15.77	45.47	104.86	2.64
parietal lobe, fetal, donor1	10072-101I9	8.73	12.61	36.85	4.85
parietal lobe, newborn, donor10223	10356-105E5	20.56	27.67	63.18	2.99
parotid gland, adult	10199-103F1	7.40	2.47	5.55	1.23
penis, adult	10200-103F2	4.83	5.91	13.96	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2.42	9.85	7.07	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	27.68	22.73	19.38	4.81
pineal gland - adult, donor10196	10179-103C8	30.32	83.85	96.11	6.45
pineal gland, adult, donor10252	10160-103A7	56.85	110.74	110.74	2.37
pineal gland, adult, donor10258	10377-105G8	33.23	68.98	99.70	9.41
pituitary gland - adult, donor10196	10180-103C9	10.12	23.27	56.66	2.02
pituitary gland, adult, donor10252	10162-103A9	29.71	44.30	72.44	2.08
pituitary gland, adult, donor10258	10378-105G9	9.36	30.64	69.80	2.55
placenta, adult, pool1	10021-101D3	5.27	4.73	4.52	0.97
plasma cell leukemia cell line:ARH-77	10840-111E3	37.74	33.11	20.00	5.69
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	18.83	12.61	8.25	2.65
pons, adult, pool1	10033-101E6	13.68	41.83	88.82	3.44
postcentral gyrus, adult, pool1	10032-101E5	15.17	42.72	119.69	3.75
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	10.46	10.46	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	71.60	5.51	5.51	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	35.21	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	33.36	27.97	24.76	7.87
prostate cancer cell line:PC-3	10439-106E7	41.56	38.84	33.40	8.53
prostate, adult, pool1	10022-101D4	6.26	7.44	10.16	1.00
putamen, adult, donor10196	10176-103C5	15.58	33.05	58.78	5.19
putamen, adult, donor10252	10152-102I8	5.88	11.76	23.53	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	32.78	43.71	16.39
putamen, adult, donor10258, tech_rep2	10372-105G3	17.15	31.89	59.68	4.59
putamen, newborn, donor10223	10365-105F5	26.24	19.49	23.99	3.75
rectal cancer cell line:TT1TKB	10469-106I1	18.33	21.24	9.02	4.07
rectum, fetal, donor1	10067-101I4	18.08	8.35	20.86	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	36.46	15.69	16.11	5.09
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	3.31	5.80	9.53	0.83
retina, adult, pool1	10030-101E3	9.74	15.80	22.46	2.29
retinoblastoma cell line:Y79	10475-106I7	31.70	64.43	58.72	22.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	27.54	22.13	50.29	4.79
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	13.78	21.65	15.75	6.75
sacrococcigeal teratoma cell line:HTST	10695-109G2	5.30	5.30	5.30	2.27
salivary acinar cells, donor1	11771-123I7	12.46	5.02	8.25	0.97
salivary acinar cells, donor2	11772-123I8	9.09	5.23	8.67	1.65
salivary acinar cells, donor3	11773-123I9	1.99	1.32	5.96	0.66
salivary gland, adult, pool1	10093-102C3	4.58	4.58	10.30	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	8.01	11.80	11.47	2.95
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	9.29	8.82	10.46	2.47
seminal vesicle, adult	10201-103F3	15.34	8.99	7.41	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	25.75	17.49	17.00	5.10
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	23.91	18.37	15.10	2.77
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	30.11	33.12	39.14	6.02
serous cystadenocarcinoma cell line:HTOA	10693-109F9	15.31	16.79	11.01	2.42
signet ring carcinoma cell line:Kato III	10436-106E4	2.76	2.65	1.99	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	56.38	32.13	17.68	7.87
skeletal muscle - soleus muscle, donor1	10282-104F3	2.84	9.93	23.41	2.13
skeletal muscle, adult, pool1	10023-101D5	5.88	11.51	22.79	1.32
skeletal muscle, fetal, donor1	10066-101I3	3.02	11.06	7.04	0.00
skin, adult, donor1	10074-102A2	20.36	13.57	6.79	0.00
skin, fetal, donor1	10065-101I2	8.21	9.47	10.73	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	29.35	23.68	20.01	6.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	28.37	37.82	39.40	6.62
small cell lung carcinoma cell line:DMS 144	10841-111E4	6.17	8.87	21.01	3.28
small cell lung carcinoma cell line:LK-2	10541-107H1	15.99	16.65	10.71	4.29
small cell lung carcinoma cell line:NCI-H82	10842-111E5	18.18	72.06	60.80	7.72
small cell lung carcinoma cell line:WA-hT	10562-108A4	39.01	40.10	35.74	7.85
small intestine, adult, pool1	10024-101D6	23.05	12.30	7.52	2.39
small intestine, fetal, donor1	10064-101I1	11.06	9.58	5.16	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	46.16	31.29	25.13	5.64
smooth muscle, adult, pool1	10048-101G3	4.65	5.69	13.18	2.07
somatostatinoma cell line:QGP-1	10781-110G7	7.77	9.92	13.13	2.68
spinal cord - adult, donor10196	10181-103D1	4.36	8.95	27.30	1.61
spinal cord, adult, donor10252	10159-103A6	8.28	14.59	11.83	1.97
spinal cord, adult, donor10258	10369-105F9	3.46	13.84	28.36	1.38
spinal cord, fetal, donor1	10056-101H2	4.88	23.17	26.22	3.05
spinal cord, newborn, donor10223	10359-105E8	16.07	22.50	23.88	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	7.92	9.71	8.96	2.69
spleen, adult, pool1	10025-101D7	13.88	10.02	7.93	1.65
spleen, fetal, pool1	10044-101F8	11.04	11.12	8.82	1.51
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	43.48	39.65	26.29	7.04
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	18.61	11.58	17.28	2.28
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	7.34	6.29	16.42	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	24.24	41.83	17.98	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	20.26	38.27	34.89	3.60
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	70.32	86.84	49.56	16.94
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	42.31	32.15	11.85	9.73
stomach, fetal, donor1	10062-101H8	11.75	8.54	14.95	5.34
submaxillary gland, adult	10202-103F4	3.42	6.27	9.11	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	4.57	9.97	6.85	0.62
substantia nigra, adult, donor10258	10371-105G2	7.76	20.17	71.38	2.59
substantia nigra, newborn, donor10223	10358-105E7	6.36	7.07	14.84	2.83
synovial sarcoma cell line:HS-SY-II	10441-106E9	30.49	30.26	40.35	8.94
temporal lobe, adult, pool1	10031-101E4	14.67	36.20	87.48	1.70
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	11.40	20.66	26.35	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	9.67	15.38	24.61	3.08
tenocyte, donor1	11763-123H8	18.50	9.08	7.33	3.49
tenocyte, donor2	11765-123I1	6.49	4.58	2.67	0.00
tenocyte, donor3	11768-123I4	11.12	11.12	7.41	3.34
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	71.89	67.47	52.01	19.04
teratocarcinoma cell line:NCR-G1	10798-110I6	12.18	24.51	14.64	4.62
teratocarcinoma cell line:PA-1	10807-111A6	37.35	44.79	17.98	8.99
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	20.95	15.11	8.38	4.44
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	33.28	17.77	15.51	9.08
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	16.58	8.72	4.58	2.07
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	64.49	43.32	24.75	13.03
testis, adult, pool1	10026-101D8	25.23	93.09	33.29	2.68
testis, adult, pool2	10096-102C6	25.71	142.99	69.47	5.41
thalamus - adult, donor10196	10168-103B6	6.62	29.81	49.68	2.21
thalamus, adult, donor10252	10154-103A1	4.53	9.22	13.28	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	15.40	93.92	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.11	15.48	29.81	0.99
thalamus, newborn, donor10223	10366-105F6	18.99	22.44	40.85	4.03
throat, adult	10209-103G2	5.99	5.74	9.49	1.00
throat, fetal, donor1	10061-101H7	10.66	10.36	9.14	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	33.39	49.68	33.19	9.54
thymus, adult, pool1	10027-101D9	26.64	18.49	8.35	5.47
thymus, fetal, pool1	10043-101F7	30.03	27.85	11.64	4.88
thyroid carcinoma cell line:KHM-5M	10776-110G2	77.52	52.39	30.45	13.83
thyroid carcinoma cell line:TCO-1	10783-110G9	22.07	39.25	22.49	4.05
thyroid, adult, pool1	10028-101E1	14.18	12.97	14.93	2.33
thyroid, fetal, donor1	10060-101H6	11.60	9.76	14.77	2.37
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	3.08	30.80	0.00
tongue, adult	10203-103F5	10.70	6.05	12.09	2.09
tongue, fetal, donor1	10059-101H5	10.25	14.19	19.70	1.58
tonsil, adult, pool1	10047-101G2	16.73	13.12	15.23	2.80
trachea, adult, pool1	10029-101E2	15.30	8.43	8.02	1.96
trachea, fetal, donor1	10058-101H4	7.31	8.08	16.16	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	16.65	20.55	12.75	3.90
transitional-cell carcinoma cell line:5637	10418-106C4	28.98	22.19	14.89	5.78
transitional-cell carcinoma cell line:JMSU1	10492-107B6	27.26	27.42	13.32	9.40
tridermal teratoma cell line:HGRT	10694-109G1	5.71	3.81	5.71	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	14.31	13.04	9.14	3.98
umbilical cord, fetal, donor1	10057-101H3	14.61	0.00	10.43	0.00
uterus, adult, pool1	10100-102D1	5.46	8.53	14.84	0.68
uterus, fetal, donor1	10055-101H1	9.21	11.26	16.38	2.56
vagina, adult	10204-103F6	5.17	13.57	5.82	2.58
vein, adult	10191-103E2	9.43	8.77	5.48	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	16.02	31.24	27.24	3.20